ENGN: enGene Holdings Inc. Company Short-Term Debt
enGene Holdings Inc. (ENGN) is developing cutting-edge gene therapy methods by collaborating with top urological and oncology centers to combat bladder cancer. The business relies on an autonomous product cycle, rendering it resilient to global crises. The current metric stands at 0.00. This chart illustrates the price action of the company's short-term debt obligations.
Metric breakdowns and analytics for enGene Corp (ENGN)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital enGene Holdings Inc.|ENGN - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity enGene Holdings Inc.|ENGN - Company Total Debt|Debt to Book Capitalization Ratio enGene Holdings Inc.|ENGN - Company Long-Term Liabilities|Company Current Liabilities enGene|Quick Liquidity engene.com
- net income and valuation multiples indicators:
Initial company analysis:ENGN - enGene
enGene Holdings Inc. is developing an innovative non-viral gene therapy delivery platform that requires significant capital expenditures. The total volume of liabilities maturing within one year directly reflects the issuer's current debt load. This metric measures liquidity by capturing loans due for payment within the next twelve months. By analyzing the company's short-term borrowings, an investor determines the balance between financial stability and the pace of expansion. A reduction in this indicator minimizes default risks but may limit the speed of technological growth.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Zenas Corp|Immunome, Inc. (IMNM) - Company Short-Term Debt|Company Short-Term Indebtedness GOSS|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|SEPN - Short-Term Indebtedness|Company Short-Term Debts PVLA|SVRA - Short-Term Debt|Company Short-Term Debt Rigel Pharmaceuticals RIGL|ANAB: Company Short-Term Indebtedness|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt rapt.com|JBIO (aerovatetx.com) - Company Current Liabilities|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|TLSA: Company Short-Term Loans and Borrowings|Company Short-Term Debt Cabaletta Bio (CABA)|VTYX - Short-Term Debt|Company Short-Term Debt Theratechnologies Inc THTX|Avalo Therapeutics Inc - Company Short-Term Debt|Eledon Pharmaceuticals - Company Short-Term Debts|AGEN (agenusbio.com) - Company Short-Term Indebtedness|CLYM: Company Short-Term Debts|ZURA - Short-Term Debt Volume|Company Short-Term Debt aTyr|Company Short-Term Indebtedness ADAG (Adagene Corp)|Company Short-Term Debts IMA|shattucklabs.com (STTK) - Short-Term Indebtedness|Company Short-Term Debt Equillium EQ|Short-Term Debt Volume Connect Biopharma Holdings (CNTB)|IMUX: Company Current Liabilities|Company Short-Term Loans and Borrowings ATRA (Atara Biotherapeutics)|IFRX: Company Short-Term Debts|XFOR - Short-Term Debt Volume|Company Short-Term Debt Adicet Bio Inc.|Company Short-Term Indebtedness CELU (Celularity Corp)|Company Short-Term Debts INMB|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Kezar Life Sciences - Company Current Liabilities|Short-Term Debt Volume sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Company Short-Term Debts|Short-Term Debt Enlivex Therapeutics|q32bio.com (QTTB) - Company Short-Term Debt|Company Short-Term Indebtedness GOVX|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|IBIO - Short-Term Indebtedness|Company Short-Term Debt Carisma Therapeutics (CARM)|XTL Biopharmaceuticals Ltd - Company Short-Term Indebtedness|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Current Liabilities|Aptevo - Company Short-Term Debts|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debt XORTX|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debt Revelation Biosciences (REVB)|Company Current Liabilities indaptusrx.com INDP|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD: Company Current Liabilities|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGMS - Short-Term Debt Volume|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD